1352925-73-5 Usage
General Description
3-benzyl-3-azabicyclo[3.1.1]heptan-2-one is a bicyclic ketone compound with a benzyl group attached to one of the carbon atoms in the bicyclic structure. This chemical is a derivative of the bicyclic compound azabicyclo[3.1.1]heptane, and its structure contains a seven-membered ring with a nitrogen atom. It is commonly used as a building block in organic synthesis and medicinal chemistry, and its unique structure makes it a valuable intermediate for the synthesis of various pharmaceuticals and bioactive compounds. Additionally, it possesses interesting pharmacological properties and has been investigated for potential use in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1352925-73-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,2,9,2 and 5 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1352925-73:
(9*1)+(8*3)+(7*5)+(6*2)+(5*9)+(4*2)+(3*5)+(2*7)+(1*3)=165
165 % 10 = 5
So 1352925-73-5 is a valid CAS Registry Number.
1352925-73-5Relevant articles and documents
ARYL, HETEROARY, AND HETEROCYCLIC PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS
-
Page/Page column 453; 455, (2018/09/21)
Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, and Formula V, or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.
Synthesis of a conformationally constrained δ-amino acid building block
O'Reilly, Elaine,Pes, Lara,Ortin, Yannick,Mueller-Bunz, Helge,Paradisi, Francesca
, p. 511 - 518 (2013/07/27)
Conformationally restricted amino acids are important components in peptidomimetics and drug design. Herein, we describe the synthesis of a novel, non-proteinogenic constrained delta amino acid containing a cyclobutane ring, cis-3(aminomethyl)cyclobutane
